Hemorrhagic transformation in focal cerebral ischemia: influence of time to artery reopening and tissue plasminogen activator.
- 1 February 1999
- journal article
- research article
- Published by Wiley in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
- Vol. 19 (2) , 139-142
- https://doi.org/10.1592/phco.19.3.139.30932
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Acute Hypertension Promotes Hemorrhagic Transformation in a Rabbit Embolic Stroke Model: Effect of LabetalolExperimental Neurology, 1998
- Acute Hypertension, but Not Thrombolysis, Increases the Incidence and Severity of Hemorrhagic Transformation Following Experimental Stroke in RabbitsExperimental Neurology, 1996
- Tissue Plasminogen Activator for Acute Ischemic StrokeNew England Journal of Medicine, 1995
- Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic strokeThe Lancet, 1995
- Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)JAMA, 1995
- Termination of trial of streptokinase in severe acute ischaemic strokeThe Lancet, 1995
- Factors related to intracranial hematoma formation in patients receiving tissue-type plasminogen activator for acute ischemic stroke.Stroke, 1994
- Hemorrhagic InfarctsEuropean Neurology, 1994
- Hemorrhagic infarct conversion in experimental strokeAnnals of Emergency Medicine, 1992
- Hemorrhagic infarction: risk factors, clinical and tomographic features, and outcome A case-control studyActa Neurologica Scandinavica, 1989